Related references
Note: Only part of the references are listed.Complement factor H in host defense and immune evasion
Raffaella Parente et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2017)
C5 nephritic factors drive the biological phenotype of C3 glomerulopathies
Maria-Chiara Marinozzi et al.
KIDNEY INTERNATIONAL (2017)
Atypical hemolytic uremic syndrome and C3 glomerulopathy: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
Timothy H. J. Goodship et al.
KIDNEY INTERNATIONAL (2017)
Rituximab for Treatment of Membranoproliferative Glomerulonephritis and C3 Glomerulopathies
Michael Rudnicki
BIOMED RESEARCH INTERNATIONAL (2017)
Complement analysis 2016: Clinical indications, laboratory diagnostics and quality control
Zoltan Prohaszka et al.
IMMUNOBIOLOGY (2016)
Protection of host cells by complement regulators
Christoph Q. Schmidt et al.
IMMUNOLOGICAL REVIEWS (2016)
Glomerular Diseases Dependent on Complement Activation, Including Atypical Hemolytic Uremic Syndrome, Membranoproliferative Glomerulonephritis, and C3 Glomerulopathy: Core Curriculum 2015
Marina Noris et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2015)
Remission of C3 glomerulopathy with rituximab as only immunosuppressive therapy
Philippe Giaime et al.
CLINICAL NEPHROLOGY (2015)
A novel method for direct measurement of complement convertases activity in human serum
A. M. Blom et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2014)
Rituximab fails where eculizumab restores renal function in C3nef-related DDD
Caroline Rousset-Rouviere et al.
PEDIATRIC NEPHROLOGY (2014)
Treatment options for C3 glomerulopathy
Carla M. Nester et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2013)
An international serum standard for application in assays to detect human complement activation products
Grethe Bergseth et al.
MOLECULAR IMMUNOLOGY (2013)
Recurrent Dense Deposit Disease After Renal Transplantation: An Emerging Role for Complementary Therapies
J. A. McCaughan et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2012)
Causes of Alternative Pathway Dysregulation in Dense Deposit Disease
Yuzhou Zhang et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2012)
Membranoproliferative glomerulonephritis and C3 glomerulopathy: resolving the confusion
Sanjeev Sethi et al.
KIDNEY INTERNATIONAL (2012)
Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation
Danielle Paixao-Cavalcante et al.
KIDNEY INTERNATIONAL (2012)
Factor H autoantibodies in membranoproliferative glomerulonephritis
Timothy H. J. Goodship et al.
MOLECULAR IMMUNOLOGY (2012)
Functional Analyses of Complement Convertases Using C3 and C5-Depleted Sera
Marcin Okroj et al.
PLOS ONE (2012)
Membranoproliferative glomerulonephritis with C3NeF and genetic complement dysregulation
Valerie Leroy et al.
PEDIATRIC NEPHROLOGY (2011)
Dual interaction of factor H with C3d and glycosaminoglycans in host-nonhost discrimination by complement
Tommi Kajander et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Complement: a key system for immune surveillance and homeostasis
Daniel Ricklin et al.
NATURE IMMUNOLOGY (2010)
Characterization of the Complement Inhibitory Function of Rhesus Rhadinovirus Complement Control Protein (RCP)
Marcin Okroj et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
A hemolytic method for the measurement of nephritic factor
Clark D. West
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Transient transfection factors for high-level recombinant protein production in suspension cultured mammalian cells
Chaoting Liu et al.
MOLECULAR BIOTECHNOLOGY (2008)
Anti-factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome
Mihaly Jozsi et al.
BLOOD (2007)
Primary glomerulonephritis with isolated C3 deposits:: a new entity which shares common genetic risk factors with haemolytic uraemic syndrome
Aude Servais et al.
JOURNAL OF MEDICAL GENETICS (2007)
Gain-of-function mutations in complement factor B are associated with atypical hemolytic uremic syndrome
Elena Goicoechea de Jorge et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
New approaches to the treatment of dense deposit disease
Richard J. H. Smith et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
Decay-accelerating factor must bind both components of the complement alternative pathway C3 convertase to mediate efficient decay
Claire L. Harris et al.
JOURNAL OF IMMUNOLOGY (2007)
The role of complement in autoimmune renal disease
M. A. Seelen et al.
AUTOIMMUNITY (2006)
Natural antibodies, autoantibodies and complement activation in tissue injury
Sherry D. Fleming
AUTOIMMUNITY (2006)
Molecular dissection of the α-dystroglycan- and integrin-binding sites within the globular domain of human laminin-10
H Ido et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Complement analysis in children with idiopathic membranoproliferative glomerulonephritis:: A long-term follow-up
R Schwertz et al.
PEDIATRIC ALLERGY AND IMMUNOLOGY (2001)
Share Paper
